Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the safety and tolerability of BMS-663513 in subjects with advanced and/or metastatic malignant tumors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02534506
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 1
Start date	November 6, 2015
Completion date	November 11, 2016

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02041871` - Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer	N/A
	Completed	`NCT03110783` - Bioseal Dural Sealing Study BIOS-14-001	Phase 3
	Recruiting	`NCT05516914` - A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors	Phase 1/Phase 2
	Recruiting	`NCT05714748` - Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors	Phase 1
	Recruiting	`NCT05987098` - BBPA PET/CT in Patients With Malignant Tumors	N/A
	Not yet recruiting	`NCT01092247` - The Effect of Ketogenic Diet on Malignant Tumors- Recurrence and Progress	N/A
	Recruiting	`NCT03160599` - Restricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors	N/A
	Recruiting	`NCT04702841` - CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors	Early Phase 1
	Completed	`NCT00165100` - Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer	N/A
	Suspended	`NCT05615974` - A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors	Phase 1/Phase 2
	Completed	`NCT03542773` - Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET	Phase 1
	Completed	`NCT05293990` - Usefulness of Gadovist-enhanced FLAIR Imaging	N/A
	Completed	`NCT01509612` - Additive Homeopathy in Cancer Patients	Phase 3
	Completed	`NCT01678690` - An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors	Phase 0
	Suspended	`NCT06270394` - FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application	N/A
	Completed	`NCT00412503` - Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents	Phase 1